Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli

Saudi Pharmaceutical Journal

Volumn 26, Issue 5, 2018, Pages 603-607

  Abdelhamid, Ahmed G ^a   Esaam, Aliaa ^a   Hazaa, Mahmoud M ^a  

^a BENHA UNIVERSITY   (Egypt)

Author keywords

Bifidobacterium; E. coli; Lactobacillus; Multidrug resistance; Probiotics

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; PROBIOTIC AGENT;

AGAR DIFFUSION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BIOFILM; CELL FREE SYSTEM; CONTROLLED STUDY; INTENSIVE CARE UNIT; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS HELVETICUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; MILK; MULTIDRUG RESISTANCE; NONHUMAN; PATHOGENIC ESCHERICHIA COLI;

EID: 85043507268     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2018.03.004     Document Type: Article

References (39)

1. Alfaleh, K., Anabrees, J., Bassler, D., Al-Kharfi, T., 2011. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. CD005496. http://doi.org/10.1097/AOG.0b013e3181726f2f.
2. Arora, D.S., Kaur, J., Antimicrobial activity of spices. Int. J. Antimicrob. Agents 12 (1999), 257–262, 10.1016/S0924-8579(99)00074-6.
3. Bayoumi, M.A., Griffiths, M.W., In vitro inhibition of expression of virulence genes responsible for colonization and systemic spread of enteric pathogens using Bifidobacterium bifidum secreted molecules. Int. J. Food Microbiol. 156 (2012), 255–263.
4. Beloin, C., Roux, A., Ghigo, J.M., 2008. Escherichia coli biofilms. Curr. Top. Microbiol. Immunol. http://doi.org/10.1007/978-3-540-75418-3_12.
5. Biemer, J.J., Antimicrobial susceptibility testing by the Kirby-Bauer disc diffusion method. Ann. Clin. Lab. Sci. 3 (1973), 135–140.
6. Candela, M., Perna, F., Carnevali, P., Vitali, B., Ciati, R., Gionchetti, P., Rizzello, F., Campieri, M., Brigidi, P., Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int. J. Food Microbiol. 125 (2008), 286–292, 10.1016/j.ijfoodmicro.2008.04.012.
7. Chai, W., Burwinkel, M., Wang, Z., Palissa, C., Esch, B., Twardziok, S., Rieger, J., Wrede, P., Schmidt, M.F.G., Antiviral effects of a probiotic Enterococcus faecium strain against transmissible gastroenteritis coronavirus. Arch. Virol. 158 (2013), 799–807, 10.1007/s00705-012-1543-0.
8. Collignon, P., Resistant Escherichia coli—We Are What We Eat. July) @BULLET Editor. Comment. Clin. Infect. Dis. 49 (2009), 202–204, 10.1086/599831.
9. Croxen, M.A., Brett Finlay, B., Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol., 11, 2012, 141, 10.1038/nrmicro2953.
10. Cruz, J.M., Domínguez, J.M., Domínguez, H., Parajó, J.C., Antioxidant and antimicrobial effects of extracts from hydrolysates of lignocellulosic materials. J. Agric. Food Chem. 49 (2001), 2459–2464.
11. Djordjevic, D., Wiedmann, M., McLandsborough, L.A., Microtiter plate assay for assessment of Listeria monocytogenes biofilm formation. Appl. Environ. Microbiol. 68 (2002), 2950–2958, 10.1128/AEM.68.6.2950-2958.2002.
12. Drider, D., Bendali, F., Naghmouchi, K., Chikindas, M.L., Bacteriocins: not only antibacterial agents. Probiotics Antimicrob. Proteins 8 (2016), 177–182, 10.1007/s12602-016-9223-0.
13. Erdem, A.L.A.L., Avelino, F., Xicohtencatl-Cortes, J., Giron, J.A., Giron, J.A., Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli. J. Bacteriol. 189 (2007), 7426–7435, 10.1128/JB.00464-07.
14. Friedman, G., 2012. The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea and Clostridium Difficile colitis. Gastroenterol. Clin. North Am. http://doi.org/10.1016/j.gtc.2012.08.002.
15. Jadhav, S., Shah, R., Bhave, M., Palombo, E.A., Inhibitory activity of yarrow essential oil on Listeria planktonic cells and biofilms. Food Control 29 (2013), 125–130, 10.1016/j.foodcont.2012.05.071.
16. Kaboosi, H., Antibacterial effects of probiotics isolated from yoghurts against some common bacterial pathogens. Afr. J. Microbiol. Res. 5 (2011), 4363–4367, 10.5897/AJMR11.474.
17. Kaper, J.B., Nataro, J.P., Harry, L.T.M., Mobley, H.L., Pathogenic Escherichia coli. Nat. Rev. Microbiol., 2, 2004, 123, 10.1038/nrmicro818.
18. Kim, Y., oh, S., Kim, S.H., Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7. Biochem. Biophys. Res. Commun. 379 (2009), 324–329, 10.1016/j.bbrc.2008.12.053.
19. Li, X.F., Liu, Z.J., Chen, X., Li, J., Cui, Z.G., Kan, B., Ma, J.R., Cui, J.H., Study on antibiotic resistance of Escherichia coli and Enterococcus colonized in intestine of neonates from neonatal intensive care unit. Zhonghua Liu Xing Bing Xue Za Zhi 38 (2017), 1259–1262.
20. Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., Harbarth, S., Hindler, J.F., Kahlmeter, G., Olsson-Liljequist, B., Paterson, D.L., Rice, L.B., Stelling, J., Struelens, M.J., Vatopoulos, A., Weber, J.T., Monnet, D.L., Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18 (2012), 268–281, 10.1111/j.1469-0691.2011.03570.x.
21. Martinez-Medina, M., Naves, P., Blanco, J., Aldeguer, X., Blanco, J.E., Blanco, M., Ponte, C., Soriano, F., Darfeuille-Michaud, A., Garcia-Gil, L.J., Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC). BMC Microbiol., 9, 2009, 202, 10.1186/1471-2180-9-202.
22. Medellin-Pena, M., Wang, H., Johnson, R., Anand, S., Griffiths, M.W., Probiotics affect virulence-related gene expression in Escherichia coli O157: H7. Appl. Environ. Microbiol., 73, 2007, 4259.
23. Medellin-Peña, M.J., Griffiths, M.W., Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization. Appl. Environ. Microbiol. 75 (2009), 1165–1172, 10.1128/AEM.01651-08.
24. Minocha, A., Probiotics for preventive health. Nutr. Clin. Pract. 24 (2009), 227–241, 10.1177/0884533608331177.
25. Mubita, C., Syakalima, M., Chisenga, C., Munyeme, M., Bwalya, M., Chifumpa, G., Hang'ombe, B.M., Sinkala, P., Simuunza, M., Fukushi, H., Isogai, H., Yasuda, J., Isogai, E., Antibiograms of faecal Escherichia coli and Enterococci species isolated from pastoralist cattle in the interface areas of the Kafue basin in Zambia - Short communication. Vet. Arh. 78 (2008), 179–185.
26. Nakai, H., Hagihara, M., Kato, H., Hirai, J., Nishiyama, N., Koizumi, Y., Sakanashi, D., Suematsu, H., Yamagishi, Y., Mikamo, H., Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. J. Infect.Chemother. 22 (2016), 319–326, 10.1016/j.jiac.2016.02.004.
27. Nataro, J.P., Steiner, T., Guerrant, R.L., 1998. Enteroaggregative Escherichia coli. Emerg. Infect. Dis.
28. Noordiana, N., Fatimah, A.B., Mun, A.S., Antibacterial agents produced by lactic acid bacteria isolated from Threadfin Salmon and Grass Shrimp. Int. Food Res. J. 20 (2013), 117–124.
29. Paterson, D.L., Bonomo, R.A., Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18 (2005), 657–686, 10.1128/CMR.18.4.657.
30. Römling, U., Balsalobre, C., Biofilm infections, their resilience to therapy and innovative treatment strategies. J. Intern. Med., 2012, 10.1111/joim.12004.
31. Schultz, M., 2008. Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm. Bowel Dis. http://doi.org/10.1002/ibd.20377.
32. Tadesse, D.A., Zhao, S., Tong, E., Ayers, S., Singh, A., Bartholomew, M.J., McDermott, P.F., 2012. Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950–2002. Emerg. Infect. Dis. http://doi.org/10.3201/eid1805.111153.
33. Tejero-Sariñena, S., Barlow, J., Costabile, A., Gibson, G.R., Rowland, I., Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains?. Anaerobe 24 (2013), 60–65, 10.1016/j.anaerobe.2013.09.011.
34. Tejero-Sariñena, S., Barlow, J., Costabile, A., Gibson, G.R., Rowland, I., In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: evidence for the effects of organic acids. Anaerobe 18 (2012), 530–538, 10.1016/j.anaerobe.2012.08.004.
35. Torres, A.G., 2009. Intestinal pathogenic Escherichia coli. In: Vaccines for Biodefense and Emerging and Neglected Diseases. pp. 1013–1029. http://doi.org/10.1016/B978-0-12-369408-9.00051-2.
36. Vuotto, C., Longo, F., Donelli, G., 2014. Probiotics to counteract biofilm-associated infections: Promising and conflicting data. Int. J. Oral Sci. http://doi.org/10.1038/ijos.2014.52.
37. Wall, G.C., Schirmer, L.L., Anliker, L.E., Tigges, A.E., Pharmacotherapy for acute pouchitis. Ann. Pharmacother. 45 (2011), 1127–1137, 10.1345/aph.1P790.
38. Yang, J., Huang, K., Qin, S., Wu, X., Zhao, Z., Chen, F., Antibacterial action of selenium-enriched probiotics against pathogenic Escherichia coli. Dig. Dis. Sci. 54 (2009), 246–254, 10.1007/s10620-008-0361-4.
39. Yang, S.-C., Lin, C.-H., Sung, C.T., Fang, J.-Y., Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front. Microbiol., 5, 2014, 241, 10.3389/fmicb.2014.00241.